Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12363 | Dusigitumab | 2 | Completed | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12363 | Dusigitumab | 2 | Completed | 1 |